Spots Global Cancer Trial Database for l2 childhood acute lymphoblastic leukemia

Every month we try and update this database with for l2 childhood acute lymphoblastic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia	NCT00049569	L1 Childhood Ac... L2 Childhood Ac... Non-T, Non-B Ch... Recurrent Child... T-cell Childhoo...	cytarabine methotrexate vincristine sul... prednisone pegaspargase doxorubicin hyd... imatinib mesyla... cyclophosphamid... etoposide filgrastim leucovorin calc... asparaginase therapeutic hyd...	1 Year - 21 Years	National Cancer Institute (NCI)
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia	NCT00381680	B-cell Childhoo... L1 Childhood Ac... L2 Childhood Ac... Intermediate Ri...	vincristine sul... prednisone doxorubicin hyd... pegaspargase cytarabine methotrexate dexamethasone etoposide cyclophosphamid... leucovorin calc... filgrastim asparaginase mercaptopurine	1 Year - 29 Years	Children's Oncology Group
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00002744	Leukemia	asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... mercaptopurine methotrexate pegaspargase prednisone therapeutic hyd... thioguanine vincristine sul... low-LET cobalt-... low-LET photon ...	1 Year - 9 Years	Children's Oncology Group
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia	NCT00002744	Leukemia	asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... mercaptopurine methotrexate pegaspargase prednisone therapeutic hyd... thioguanine vincristine sul... low-LET cobalt-... low-LET photon ...	1 Year - 9 Years	Children's Oncology Group
Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia	NCT00003729	Leukemia	cytarabine fludarabine pho... idarubicin	- 17 Years	European Organisation for Research and Treatment of Cancer - EORTC
Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia	NCT00002812	Leukemia	asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... idarubicin mercaptopurine methotrexate pegaspargase prednisone thioguanine vincristine sul... radiation thera...	1 Year - 21 Years	Children's Oncology Group
Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia	NCT00061945	Acute Undiffere... B-cell Adult Ac... B-cell Childhoo... L1 Adult Acute ... L1 Childhood Ac... L2 Adult Acute ... L2 Childhood Ac... Philadelphia Ch... Philadelphia Ch... Philadelphia Ch... T-cell Adult Ac... T-cell Childhoo... Untreated Adult... Untreated Child...	allopurinol cyclophosphamid... daunorubicin hy... vincristine sul... dexamethasone asparaginase filgrastim imatinib mesyla... methotrexate cytarabine trimethoprim-su... mercaptopurine leucovorin calc... alemtuzumab acyclovir laboratory biom... pharmacological...	15 Years -	National Cancer Institute (NCI)
Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia	NCT00022126	Leukemia	asparaginase cyclophosphamid... cyclosporine cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... mercaptopurine methotrexate methylprednisol... pegaspargase thioguanine vincristine sul... allogeneic bone... radiation thera...	- 1 Year	Children's Oncology Group
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia	NCT00381680	B-cell Childhoo... L1 Childhood Ac... L2 Childhood Ac... Intermediate Ri...	vincristine sul... prednisone doxorubicin hyd... pegaspargase cytarabine methotrexate dexamethasone etoposide cyclophosphamid... leucovorin calc... filgrastim asparaginase mercaptopurine	1 Year - 29 Years	Children's Oncology Group
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission	NCT00382109	B-cell Childhoo... Childhood Acute... Graft Versus Ho... L1 Childhood Ac... L2 Childhood Ac... T-cell Childhoo...	thiotepa cyclophosphamid... tacrolimus methotrexate sirolimus total body irra...	1 Year - 21 Years	Children's Oncology Group
Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia	NCT00019409	Leukemia	asparaginase cyclophosphamid... cytarabine daunorubicin hy... mercaptopurine methotrexate prednisone therapeutic hyd... vincristine sul... radiation thera...	1 Year - 20 Years	National Institutes of Health Clinical Center (CC)
Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma	NCT00003728	Leukemia Lymphoma	asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... etoposide leucovorin calc... mercaptopurine methotrexate methylprednisol... mitoxantrone hy... prednisolone therapeutic hyd... thioguanine vincristine sul... vindesine allogeneic bone... peripheral bloo...	- 17 Years	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia	NCT00003729	Leukemia	cytarabine fludarabine pho... idarubicin	- 17 Years	European Organisation for Research and Treatment of Cancer - EORTC
Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome	NCT00005593	Leukemia Myelodysplastic...	carboplatin fludarabine pho... topotecan hydro...	12 Years -	Case Comprehensive Cancer Center
Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia	NCT00003783	Leukemia	filgrastim asparaginase cyclophosphamid... cytarabine daunorubicin hy... dexamethasone etoposide idarubicin leucovorin calc... mercaptopurine methotrexate prednisone vincristine sul... radiation thera...	- 17 Years	Children's Oncology Group
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia	NCT00381680	B-cell Childhoo... L1 Childhood Ac... L2 Childhood Ac... Intermediate Ri...	vincristine sul... prednisone doxorubicin hyd... pegaspargase cytarabine methotrexate dexamethasone etoposide cyclophosphamid... leucovorin calc... filgrastim asparaginase mercaptopurine	1 Year - 29 Years	Children's Oncology Group
Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia	NCT00005945	Leukemia	cyclophosphamid... cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... mercaptopurine methotrexate pegaspargase thioguanine vincristine sul... radiation thera...	1 Year - 9 Years	Children's Oncology Group
Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia	NCT00049569	L1 Childhood Ac... L2 Childhood Ac... Non-T, Non-B Ch... Recurrent Child... T-cell Childhoo...	cytarabine methotrexate vincristine sul... prednisone pegaspargase doxorubicin hyd... imatinib mesyla... cyclophosphamid... etoposide filgrastim leucovorin calc... asparaginase therapeutic hyd...	1 Year - 21 Years	National Cancer Institute (NCI)
Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia	NCT00022126	Leukemia	asparaginase cyclophosphamid... cyclosporine cytarabine daunorubicin hy... dexamethasone doxorubicin hyd... mercaptopurine methotrexate methylprednisol... pegaspargase thioguanine vincristine sul... allogeneic bone... radiation thera...	- 1 Year	Children's Oncology Group
Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome	NCT00005593	Leukemia Myelodysplastic...	carboplatin fludarabine pho... topotecan hydro...	12 Years -	Case Comprehensive Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: